4.7 Review

Emerging role of mesenchymal stromal cells in gynecologic cancer therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Photo-sonodynamic therapy mediated with OLI_NPs to induce HPV16E7-specific immune response and inhibit cervical cancer in a murine model

Guangzong Zhao et al.

Summary: This study reported the synthesis of a new nanoparticle system that can diagnose and treat tumors simultaneously. By combining photo-sonodynamic therapy (PSDT) with the nanoparticles, it was found to induce systemic antitumor immune responses and effectively inhibit tumor development.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2023)

Article Cell & Tissue Engineering

Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI)

Li Ling et al.

Summary: The SDF-1/CXCR4 axis partially mediates the migration and homing of systemically transplanted hAD-MSCs to the ovaries of rats with chemotherapy-induced POI, and the PI3K/Akt signaling pathway might be involved in the migration and homing of hAD-MSCs mediated by the SDF-1/CXCR4 axis.

STEM CELL RESEARCH & THERAPY (2022)

Review Pharmacology & Pharmacy

Mesenchymal stem cells: A living carrier for active tumor-targeted delivery

Tianyuan Zhang et al.

Summary: Using mesenchymal stem cells (MSCs) as a living carrier for active delivery of therapeutic agents targeting tumor sites has shown promising potential in tumor treatment. MSCs have strong tumor targeting and penetration abilities, and they actively participate in immunomodulation of the tumor microenvironment. This review highlights the active properties of MSCs, discusses the advantages and challenges of using them for tumor-targeted delivery, and summarizes recent examples of utilizing MSCs for tumor-targeted therapy.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Biochemistry & Molecular Biology

Differences in chemotaxis of human mesenchymal stem cells and cervical cancer cells

Yizuo Song et al.

Summary: This study found that MSCs from different tissues exhibit different chemotaxis towards cervical cancer cells, with chorion-derived MSC (CD-MSC) showing the strongest tropic capacity. The CXCL12/CXCR4 pathway was identified to contribute to the differential chemotaxis of MSCs to cervical cancer cells.

APOPTOSIS (2022)

Review Biochemistry & Molecular Biology

Different Sources of Mesenchymal Stem Cells for Tissue Regeneration: A Guide to Identifying the Most Favorable One in Orthopedics and Dentistry Applications

Victor J. Costela-Ruiz et al.

Summary: The success of regenerative medicine depends on the appropriate selection of mesenchymal stem cell (MSC) sources, as they influence the regenerative milieu. MSCs from bone marrow, adipose tissue, and dental tissue are all potential candidates for oral and dental regeneration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer

Isabel Heidegger et al.

Summary: This study provides a comprehensive analysis of prostate cancer tumor endothelial cells (TEC) and identifies potential therapeutic targets, specifically the CXCL12/CXCR4 interaction, to interfere with tumor angiogenesis in prostate cancer. Understanding the cell-to-cell communication networks in the tumor microenvironment contributes to the development of new therapeutic approaches for prostate cancer.

MOLECULAR CANCER (2022)

Review Biotechnology & Applied Microbiology

Macrophages as tools and targets in cancer therapy

Alberto Mantovani et al.

Summary: This review discusses the molecular mechanisms of macrophage reprogramming in the tumor microenvironment and provides an overview of macrophage-targeted therapies for cancer treatment.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Engineering, Biomedical

Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy

Lanhong Su et al.

Summary: This study proposes a strategy to improve cancer immunotherapy by utilizing red blood cell-based vaccines (RBC-vaccines) that anchor chemotherapy-induced tumor antigens (cAgs) onto red blood cells (RBCs). The RBC-vaccines significantly enhance the efficacy of immunotherapy and establish durable antitumor immunity.

ACTA BIOMATERIALIA (2022)

Article Oncology

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

Deborah K. Armstrong et al.

Journal of the National Comprehensive Cancer Network (2022)

Article Multidisciplinary Sciences

Wharton jelly-derived mesenchymal stem cell exosomes induce apoptosis and suppress EMT signaling in cervical cancer cells as an effective drug carrier system of paclitaxel

Burcin Irem Abas et al.

Summary: MSC-derived exosomes loaded with paclitaxel showed a therapeutic effect in cervical cancer cells, inducing apoptosis and suppressing epithelial-mesenchymal transition proteins.

PLOS ONE (2022)

Article Oncology

In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model

Juan Sendon-Lago et al.

Summary: In this study, the in vivo antitumor effect of human uterine cervical stem cell conditioned medium (hUCESC-CM) after intraperitoneal administration in an ovarian cancer mouse model was evaluated.

CANCER GENOMICS & PROTEOMICS (2022)

Review Biochemistry & Molecular Biology

Stem cell-based therapy for human diseases

Duc M. Hoang et al.

Summary: Recent advancements in stem cell technology have provided new treatment options for patients with untreatable diseases and disorders. Human pluripotent stem cells (hPSCs) and multipotent mesenchymal stem cells (MSCs) have emerged as important players in regenerative medicine. Clinical applications of hPSCs and MSCs derived from different tissues, such as bone marrow, adipose tissue, and umbilical cord, have shown promising results in treating neurological disorders, pulmonary dysfunctions, metabolic/endocrine-related diseases, reproductive disorders, skin burns, and cardiovascular conditions. The mechanisms underlying the therapeutic effects of these stem cells vary depending on their tissue origin.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Cell & Tissue Engineering

Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?

Umberto Galderisi et al.

Summary: Mesenchymal stromal cells (MSCs) have been widely utilized in clinical trials, particularly for treating cardiovascular diseases, GvHD, and brain and neurological disorders. Despite some successes, there have also been failures in MSC-based therapies. Integrating data from unsuccessful studies may aid in developing new therapeutic strategies to improve clinical outcomes.

STEM CELL REVIEWS AND REPORTS (2022)

Article Chemistry, Multidisciplinary

Immune Reprogramming Precision Photodynamic Therapy of Peritoneal Metastasis by Scalable Stem-Cell-Derived Extracellular Vesicles

Amandine Pinto et al.

Summary: Extracellular nanovesicles derived from mesenchymal stem/stromal cells offer a promising approach for targeted photodynamic therapy, providing superior selectivity in tumor targeting, potentiation of cytotoxicity, modulation of the tumor microenvironment, and promotion of antitumor immune response. This fourth-generation PDT vehicle shows significant enhancement in tumor selectivity and efficacy compared to traditional forms of PS delivery, presenting a potential solution to the current limitations of PDT in treating peritoneal metastasis.

ACS NANO (2021)

Review Oncology

Macrophage-Based Approaches for Cancer Immunotherapy

Nicholas R. Anderson et al.

Summary: Adoptive cell therapy with genetically modified T cells has shown promising results in hematologic malignancies, but applying it to solid tumors has been challenging. This has led to the investigation of alternative immune cells as therapeutic options. Macrophages have functional plasticity that can be harnessed for both antitumor and protumor effects, leading to efforts to deplete or repolarize tumor-associated macrophages, as well as exploring the potential of adoptively transferring genetically modified macrophages.

CANCER RESEARCH (2021)

Article Oncology

Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

Michael Chastkofsky et al.

Summary: The study demonstrates that oncolytic virus loaded MSCs can efficiently deliver to DIPG cells and release within brainstem xenografts in mice, leading to prolonged survival when combined with radiotherapy.

CLINICAL CANCER RESEARCH (2021)

Article Cell Biology

Human bone marrow mesenchymal stem cell-derived extracellular vesicles impede the progression of cervical cancer via the miR-144-3p/CEP55 pathway

Qin Meng et al.

Summary: This study found that miR-144-3p carried by EVs derived from hBMSCs can impede the development and progression of cervical cancer by inhibiting CEP55, indicating that miR-144-3p may be a potential therapeutic target for treating cervical cancer.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Microbiology

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody

Shiwen Peng et al.

Summary: Immunotherapy for cervical cancer targeting high-risk human papillomavirus types 16 and 18 shows promising results in preclinical studies, with pBI-11 DNA vaccine inducing strong immune responses and therapeutic effects in mouse models. Combination with TA-HPV boost and PD-1 antibody blockade improves tumor control and survival. Clinical translation of this strategy may provide a new approach for HPV16/18-associated tumors.
Review Oncology

Mesenchymal stem/stromal cells in cancer therapy

Tianxia Lan et al.

Summary: Multipotent mesenchymal stem/stromal cells (MSCs) have been identified in almost all tissues of the human body, showing potential in cancer treatment due to their multipotency, immunomodulation capacity, and tumor-homing property. However, controversial roles of MSCs in crosstalk with tumors hinder translational medicine progress.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Challenges and advances in clinical applications of mesenchymal stromal cells

Tian Zhou et al.

Summary: MSC therapy for clinical applications faces challenges due to inconsistent criteria for MSCs identity and their inherited heterogeneity. Strategies have been developed to overcome these challenges with the emergence of advanced biological techniques and substantial improvements in bio-engineered materials.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Engineering, Biomedical

Physiologically triggered injectable red blood cell-based gel for tumor photoablation and enhanced cancer immunotherapy

Ziying Fei et al.

Summary: An injectable gel based on red blood cells was developed for cancer photo-immunotherapy, demonstrating a durable systemic immune response and tumor rejection in mice, highlighting the potential of using RBCs for drug delivery and cancer treatment.

BIOMATERIALS (2021)

Review Medicine, General & Internal

Endometrial cancer

Vicky Makker et al.

Summary: This comprehensive review provides updates on the epidemiology, pathophysiology, diagnosis, treatment, and patient quality-of-life considerations in the management of endometrial cancer. The Primer by Makker and colleagues summarizes the epidemiology, pathophysiology, diagnosis, treatment, and future research directions for endometrial cancer.

NATURE REVIEWS DISEASE PRIMERS (2021)

Editorial Material Oncology

T Cells as the Future of Cancer Therapy

Antoni Ribas

Summary: In the next ten years, gene-engineered T-cell therapies hold promise for providing broad benefits in cancer treatment. Recent advancements in immunology, molecular biology, and bioengineering have enabled the development of gene-engineered T cells that target metastatic lesions, specifically recognize and eliminate cancer cells, and maintain long-term immunologic memory.

CANCER DISCOVERY (2021)

Article Pharmacology & Pharmacy

Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells

Qin Wang et al.

Summary: The study demonstrates that using gelatinase-stimuli nanoparticles loaded with Sal-Docetaxel can simultaneously inhibit tumor stem cells and non-stem cells, enhance anti-tumor efficacy, and reduce side effects.

DRUG DELIVERY (2021)

Review Materials Science, Biomaterials

Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery

Mian Wang et al.

Summary: MSC membrane-coated nanoparticles are an effective method for selective targeting and enhancing therapeutic efficacy. Combining bioengineered cell membranes with synthesized nanoparticles offers a wide range of possibilities for the development of targeted drug delivery.

BIOMATERIALS SCIENCE (2021)

Review Oncology

The multifaceted role of mesenchymal stem cells in cancer

Michael Timaner et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Multidisciplinary Sciences

Adipose-derived mesenchymal stem cells promote the malignant phenotype of cervical cancer

Rosario Castro-Oropeza et al.

SCIENTIFIC REPORTS (2020)

Review Immunology

Principles of adoptive T cell therapy in cancer

Ozcan Met et al.

SEMINARS IN IMMUNOPATHOLOGY (2019)

Article Biochemistry & Molecular Biology

PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma

Adria Bernat-Peguera et al.

ONCOGENE (2019)

Review Cell & Tissue Engineering

Concise Review: Mesenchymal Stem Cells: From Roots to Boost

Anna Andrzejewska et al.

STEM CELLS (2019)

Article Oncology

Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies

Dean A. Fergusson et al.

MOLECULAR THERAPY-ONCOLYTICS (2019)

Article Genetics & Heredity

The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line

Shiva Gholizadeh-Ghaleh Aziz et al.

MOLECULAR GENETICS & GENOMIC MEDICINE (2019)

Review Biotechnology & Applied Microbiology

Optimizing oncolytic virotherapy in cancer treatment

Kevin Harrington et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Chemistry, Multidisciplinary

Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic

Hong-Hui Wu et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Review Medicine, General & Internal

Cervical cancer

Paul A. Cohen et al.

LANCET (2019)

Review Multidisciplinary Sciences

Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement

Mujib Ullah et al.

ISCIENCE (2019)

Article Cell & Tissue Engineering

Enhanced Anti-Cancer Effects of Conditioned Medium from Hypoxic Human Umbilical Cord-Derived Mesenchymal Stem Cells

Kyu-Hyun Han et al.

INTERNATIONAL JOURNAL OF STEM CELLS (2019)

Article Biochemistry & Molecular Biology

STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis

Yijing Chu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Biotechnology & Applied Microbiology

Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review

Lucie Bacakova et al.

BIOTECHNOLOGY ADVANCES (2018)

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Identification of the Human Skeletal Stem Cell

Charles K. F. Chan et al.

Review Cell & Tissue Engineering

Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise

Timothy E. G. Krueger et al.

STEM CELLS TRANSLATIONAL MEDICINE (2018)

Article Hematology

PDGF regulated migration of mesenchymal stem cells towards malignancy acts via the PI3K signaling pathway

Sonia Salha et al.

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2018)

Review Biochemistry & Molecular Biology

Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine

Francisco J. Vizoso et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Cardiac & Cardiovascular Systems

Hypoxia modulates cell migration and proliferation in placenta-derived mesenchymal stem cells

Li Li et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2017)

Review Biochemistry & Molecular Biology

Mesenchymal stem cells: key players in cancer progression

Sarah M. Ridge et al.

MOLECULAR CANCER (2017)

Review Cell & Tissue Engineering

Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration

Franziska Nitzsche et al.

STEM CELLS (2017)

Review Oncology

Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy

Silvia von Karstedt et al.

NATURE REVIEWS CANCER (2017)

Review Oncology

Platinum-based drugs: past, present and future

Shahana Dilruba et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)

Article Cell & Tissue Engineering

Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells

Lenka Toro et al.

STEM CELLS AND DEVELOPMENT (2016)

Editorial Material Biotechnology & Applied Microbiology

Homing properties of mesenchymal stromal cells

Karlien Kallmeyer et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2015)

Article Chemistry, Multidisciplinary

Nano-engineered mesenchymal stem cells as targeted therapeutic carriers

Tanmoy Sadhukha et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Review Oncology

The roles of mesenchymal stem cells in tumor inflammatory microenvironment

Zhao Sun et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)

Article Cell Biology

Effect of Human Mesenchymal Stem Cells on the Growth of HepG2 and Hela Cells

Xiaohui Long et al.

CELL STRUCTURE AND FUNCTION (2013)

Review Chemistry, Multidisciplinary

Targeting and delivery of platinum-based anticancer drugs

Xiaoyong Wang et al.

CHEMICAL SOCIETY REVIEWS (2013)

Article Nanoscience & Nanotechnology

Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles

Zibin Gao et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)

Review Chemistry, Medicinal

Immunomodulatory Properties of Mesenchymal Stem Cells and Their Therapeutic Applications

TacGhee Yi et al.

ARCHIVES OF PHARMACAL RESEARCH (2012)

Review Oncology

Suicide gene therapy in cancer: Where do we stand now?

Sonia Duarte et al.

CANCER LETTERS (2012)

Article Biochemistry & Molecular Biology

Human umbilical cord wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro

Kalamegam Gauthaman et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2012)

Review Dermatology

Mesenchymal Stem Cells Home to Sites of Injury and Inflammation

Kristine C. Rustad et al.

ADVANCES IN WOUND CARE (2012)

Review Immunology

Multipotent mesenchymal stromal cells and the innate immune system

Katarina Le Blanc et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Article Oncology

Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer

Michael R. Loebinger et al.

CANCER RESEARCH (2009)

Review Cell & Tissue Engineering

Mesenchymal Stem Cell Homing: The Devil Is in the Details

Jeffrey M. Karp et al.

CELL STEM CELL (2009)

Review Immunology

Mesenchymal stem cells in health and disease

Antonio Uccelli et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Biochemistry & Molecular Biology

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

Benedetto Sacchetti et al.

Article Oncology

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

S Komarova et al.

MOLECULAR CANCER THERAPEUTICS (2006)